ARF6 mRNA expression was shown to be up-regulated approximately 5-fold in breast cancer (statistically not significant; p = 02174), 9-fold in lymphoma (statistically significantly p = 0.0309) and 57-fold in EAC (statistically significant; p = 0.0011). This evidence concerns the gene ARF6 and breast cancer.